NDC 55513-099 – Neulasta

Pegfilgrastim 4 mg/.4mL · Solution · Subcutaneous

Human Prescription Drug

Product NDC55513-099

Product details

Brand name
Neulasta
Generic name
Pegfilgrastim
Labeler
Amgen, Inc
Dosage form
Solution
Route
Subcutaneous
Marketing category
BLA · BLA125031
Marketed since
March 31, 2026
Listing expires
December 31, 2027
Pharmacologic class
Leukocyte Growth Factor

Active ingredients

Uses, dosage, side effects and warnings for Neulasta →

Package NDC codes (1)

Package NDCDescriptionSince
55513-099-011 VIAL in 1 CARTON (55513-099-01) / .4 mL in 1 VIALMar 31, 2026

Other Neulasta products